Carregant...
New Therapeutic Strategies in Advanced Nonoperable or Metastatic HER2-positive Breast Cancer
Despite therapeutic gains in the treatment of HER2-positive (HER2: human epidermal growth factor receptor 2) advanced/metastatic breast cancer, there remains an urgent need for more effective treatment options. At present, there is no definitive approved standard therapy beyond second-line treatment...
Guardat en:
| Publicat a: | Geburtshilfe Frauenheilkd |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Georg Thieme Verlag KG
2021
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8216785/ https://ncbi.nlm.nih.gov/pubmed/34168380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/a-1471-4063 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|